Neurocrine Biosciences (LSE: 0K6R) has a market capitalization of $13.91B. Last close $141.32 (as of 2026-10-21); 52-week range $118.72 to $190.00. ORTEX data as of 2026-10-19: short interest is 0.66% of free float, 421.1 days to cover and the average cost to borrow is 0.42%.